These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 28034760)

  • 1. Insulin resistance in Alzheimer's disease.
    Diehl T; Mullins R; Kapogiannis D
    Transl Res; 2017 May; 183():26-40. PubMed ID: 28034760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.
    Mullins RJ; Diehl TC; Chia CW; Kapogiannis D
    Front Aging Neurosci; 2017; 9():118. PubMed ID: 28515688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in Alzheimer's disease: The genetics and metabolomics links.
    Amin AM; Mostafa H; Khojah HMJ
    Clin Chim Acta; 2023 Jan; 539():215-236. PubMed ID: 36566957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer's disease neuropathology.
    Yang JJ
    Acta Neurol Belg; 2022 Oct; 122(5):1135-1142. PubMed ID: 35482277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.
    Mullins RJ; Mustapic M; Goetzl EJ; Kapogiannis D
    Hum Brain Mapp; 2017 Apr; 38(4):1933-1940. PubMed ID: 28105773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin: an emerging treatment for Alzheimer's disease dementia?
    Morris JK; Burns JM
    Curr Neurol Neurosci Rep; 2012 Oct; 12(5):520-7. PubMed ID: 22791280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
    de la Monte SM
    Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
    Mittal K; Katare DP
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and insulin resistance: translating basic science into clinical applications.
    De Felice FG
    J Clin Invest; 2013 Feb; 123(2):531-9. PubMed ID: 23485579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus.
    Fauzi A; Thoe ES; Quan TY; Yin ACY
    J Diabetes Complications; 2023 Nov; 37(11):108629. PubMed ID: 37866274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    Nasoohi S; Parveen K; Ishrat T
    J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and Alzheimer's Disease: A Link not as Simple as it Seems.
    Salas IH; De Strooper B
    Neurochem Res; 2019 Jun; 44(6):1271-1278. PubMed ID: 30523576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
    Lazar E; Sherzai A; Adeghate J; Sherzai D
    Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Connection Between Diabetes and Dementia.
    Chen Y; Yu Q; Gong CX
    Adv Exp Med Biol; 2019; 1128():103-131. PubMed ID: 31062327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease.
    Shen S; Liao Q; Wong YK; Chen X; Yang C; Xu C; Sun J; Wang J
    Int J Biol Sci; 2022; 18(3):983-994. PubMed ID: 35173531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome.
    Tramutola A; Lanzillotta C; Di Domenico F; Head E; Butterfield DA; Perluigi M; Barone E
    Neurobiol Dis; 2020 Apr; 137():104772. PubMed ID: 31987911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance: an emerging link in Alzheimer's disease.
    Medhi B; Chakrabarty M
    Neurol Sci; 2013 Oct; 34(10):1719-25. PubMed ID: 23670236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.
    De Sousa RAL; Harmer AR; Freitas DA; Mendonça VA; Lacerda ACR; Leite HR
    Mol Biol Rep; 2020 Aug; 47(8):6347-6356. PubMed ID: 32740795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.